Ftse Mib
33.276,89
1,12%
DAX
18.107,52
0,19%
S&P 500
5.473,23
0,77%
NASDAQ
0,00
0,00%
Bitcoin
65.282,61
-1,81%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ PolyPid Ltd (PYPD) PolyPid Ltd (PYPD) Notizie

PYPD

PolyPid (PYPD)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PYPD
DataOraFonteTitoloSimboloCompagnia
28/05/202422:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PYPDPolyPid Ltd
06/03/202422:28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PYPDPolyPid Ltd
06/03/202422:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:PYPDPolyPid Ltd
01/03/202418:19Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PYPDPolyPid Ltd
14/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PYPDPolyPid Ltd
01/02/202423:26Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:PYPDPolyPid Ltd
22/01/202414:00Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PYPDPolyPid Ltd
18/10/202323:07AllPennyStocks.comNew Collaboration Could Revolutionize Treatment of Chronic Spinal Cord InjuriesNASDAQ:PYPDPolyPid Ltd
22/06/202313:12Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:PYPDPolyPid Ltd
22/05/202315:54Dow Jones NewsFDA Approves PolyPid's Trial Design for D-PLEXNASDAQ:PYPDPolyPid Ltd
17/05/202317:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PYPDPolyPid Ltd
31/03/202321:55Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:PYPDPolyPid Ltd
31/03/202312:05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PYPDPolyPid Ltd
24/01/202316:24Dow Jones NewsPolyPid Shares Rise 28% After Positive FDA News for D-PLEXNASDAQ:PYPDPolyPid Ltd
12/12/202215:50TipRanksAnalysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
09/11/202220:45TipRanksPolyPid (PYPD) Gets a Buy from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
28/09/202219:35TipRanksJMP Securities Sticks to Its Buy Rating for PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
02/09/202218:15TipRanksJMP Securities Remains a Buy on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/08/202217:06TipRanksAnalysts’ Top Healthcare Picks: PolyPid (PYPD), Nuvalent (NUVL)NASDAQ:PYPDPolyPid Ltd
10/08/202217:15TipRanksJMP Securities Keeps Their Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/06/202215:29TipRanksBMO Capital Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/06/202220:25TipRanksJMP Securities Thinks PolyPid’s Stock is Going to RecoverNASDAQ:PYPDPolyPid Ltd
23/05/202217:25TipRanksAnalysts Offer Insights on Healthcare Companies: PolyPid (PYPD) and Nektar Therapeutics (NKTR)NASDAQ:PYPDPolyPid Ltd
12/05/202214:51TipRanksBMO Capital Keeps a Buy Rating on PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
11/05/202218:49TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Agenus (AGEN), Intercept Pharma (ICPT) and PolyPid (PYPD)NASDAQ:PYPDPolyPid Ltd
24/02/202219:18Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PYPDPolyPid Ltd
04/01/202207:53TipRanksPolypid Names New CEO; Shares Jump 6.3%NASDAQ:PYPDPolyPid Ltd
16/12/202106:25TipRanksPolyPid (PYPD) Gets a Buy Rating from JMP SecuritiesNASDAQ:PYPDPolyPid Ltd
30/08/202122:17Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:PYPDPolyPid Ltd
12/07/202112:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PYPDPolyPid Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PYPD

La tua Cronologia

BIT
F15374
Vontobel Financial Produ...
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network